Cargando…
Valproic acid is associated with cognitive decline in HIV-infected individuals: a clinical observational study
BACKGROUND: Valproic acid (VPA) is often used to control pain in HIV-related neuropathy. However, the effect of VPA on cognitive functions in advanced HIV-infected individuals is largely unknown. A recent study would suggest that it may have a neuroprotective effect, the doses used were low and the...
Autores principales: | Cysique, Lucette A, Maruff, Paul, Brew, Bruce J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1702364/ https://www.ncbi.nlm.nih.gov/pubmed/17150108 http://dx.doi.org/10.1186/1471-2377-6-42 |
Ejemplares similares
-
Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity
por: Gott, Chloe, et al.
Publicado: (2017) -
Meaningful cognitive decline is uncommon in virally suppressed HIV, but sustained impairment, subtle decline and abnormal cognitive aging are not
por: Aung, Htein Linn, et al.
Publicado: (2022) -
Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research
por: Cysique, Lucette A, et al.
Publicado: (2011) -
Validity of Cognitive Screens for HIV-Associated Neurocognitive Disorder: A Systematic Review and an Informed Screen Selection Guide
por: Kamminga, Jody, et al.
Publicado: (2013) -
Covertly active and progressing neurochemical abnormalities in suppressed HIV infection
por: Cysique, Lucette A., et al.
Publicado: (2018)